These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Expression of human telomerase reverse transcriptase in renal cell carcinoma and its clinical significance]. Wu P; Zheng SB; Zuo Y; Tan WL; Yao C; Jiang YD Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):272-4. PubMed ID: 18250061 [TBL] [Abstract][Full Text] [Related]
15. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489 [TBL] [Abstract][Full Text] [Related]
18. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244 [TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]